Back to Search Start Over

Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistance.

Authors :
Richter, Martina
Döring, Kristin
Blaas, Dieter
Riabova, Olga
Khrenova, Maria
Kazakova, Elena
Egorova, Anna
Makarov, Vadim
Schmidtke, Michaela
Source :
Antiviral Research. Feb2024, Vol. 222, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

Rhinoviruses (RVs) cause the common cold. Attempts at discovering small molecule inhibitors have mainly concentrated on compounds supplanting the medium chain fatty acids residing in the sixty icosahedral symmetry-related hydrophobic pockets of the viral capsid of the Rhinovirus-A and -B species. High-affinity binding to these pockets stabilizes the capsid against structural changes necessary for the release of the ss(+) RNA genome into the cytosol of the host cell. However, single-point mutations may abolish this binding. RV-B5 is one of several RVs that are naturally resistant against the well-established antiviral agent pleconaril. However, RV-B5 is strongly inhibited by the pyrazolopyrimidine OBR-5-340. Here, we report on isolation and characterization of RV-B5 mutants escaping OBR-5-340 inhibition and show that substitution of amino acid residues not only within the binding pocket but also remote from the binding pocket hamper inhibition. Molecular dynamics network analysis revealed that strong inhibition occurs when an ensemble of several sequence stretches of the capsid proteins enveloping OBR-5-340 move together with OBR-5-340. Mutations abrogating this dynamic, regardless of whether being localized within the binding pocket or distant from it result in escape from inhibition. Pyrazolo [3,4- d ]pyrimidine derivatives overcoming OBR-5-340 escape of various RV-B5 mutants were identified. Our work contributes to the understanding of the properties of capsid-binding inhibitors necessary for potent and broad-spectrum inhibition of RVs. [Display omitted] • Capsid-binding inhibitors of rhinoviruses (RVs) differ in molecular binding mechanism and resistance profiles. • The pyrazolo [3,4- d ]pyrimidine OBR-5-340 strongly inhibits the pleconaril-resistant RV-B5. • Some RV-B5 mutants escaping OBR-5-340 inhibition have amino acid substitutions distant from the binding pocket. • Their substitutions reduce the motion of several sequence stretches of the capsid proteins crucial for inhibitor binding. • Pyrazolo [3,4-d]pyrimidine derivatives inhibiting OBR-5-340 escape mutants of RV-B5 were identified. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01663542
Volume :
222
Database :
Academic Search Index
Journal :
Antiviral Research
Publication Type :
Academic Journal
Accession number :
175296421
Full Text :
https://doi.org/10.1016/j.antiviral.2024.105810